← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP, Global Head of R, D Martin Mackay sold $139K of Alexion Pharmaceuticals, Inc.

Sold$138,910
$138.91Price
1,000Shares
−2%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Mon, Feb 29. Filed Tue, Mar 1, 6:34 PM ET, after the close. Not investment advice.